Skip to main content Accessibility help
  • Print publication year: 2020
  • Online publication date: August 2020

Chapter 13 - Medication-Resistant Epilepsy Syndromes in Children


Medically refractory epilepsies account for 20–30% of the patients evaluated in an epilepsy centre. With more than 50% of paediatric epilepsies persisting into adulthood, it is very important for the epileptologist to have an updated understanding of the current advances in the field of medically refractory paediatric epileptic syndromes.

Refractory epilepsies are common in children. Medical intractability becomes quickly apparent after seizure onset in children with developmental epileptic encephalopathies [1].

1.Berg, AT, Vickrey, BG, Testa, FM, et al. How long does it take for epilepsy to become intractable?: a prospective investigation. Ann Neurol 2006;60(1):7379
2.Ohtahara, S, Yamatogi, Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res 2006;70(Suppl 1):S58S67
3.Pavone, P, Spalice, A, Polizzi, A, Parisi, P, Ruggieri, M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 2012;34(6):459468
4.Nieh, SE, Sherr, EH. Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics 2014;11(4):796806
5.Van Karnebeek, CD, Tiebout, SA, Niermeijer, J, et al. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatr Neurol 2016;59:612
6.Chien, YH, Lin, MI, Weng, WC, Du, JC, Lee, WT. Dextromethorphan in the treatment of early myoclonic encephalopathy evolving into migrating partial seizures in infancy. J Formos Med Assoc 2012;111(5):290294
7.Djukic, A, Lado, FA, Shinnar, S, Moshe, SL. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other? Epilepsy Res 2006;70(Suppl 1):S68S76
8.Allen, NM, Mannion, M, Conroy, J, et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia 2014;55(9):e99105
9.Maljevic, S, Lerche, H. Potassium channel genes and benign familial neonatal epilepsy. Prog Brain Res 2014;213:1753
10.Orhan, G, Bock, M, Schepers, D, et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann Neurol 2014;75(3):382394
11.Millichap, JJ, Park, KL, Tsuchida, T, et al. KCNQ2 encephalopathy: features, mutational hot spots, and ezogabine treatment of 11 patients. Neurol Genet 2016;2(5):e96
12.Numis, AL, Angriman, M, Sullivan, JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014;82(4):368370
13.Pisano, T, Numis, AL, Heavin, SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia 2015;56(5):685691
14.Pan, Z, Kao, T, Horvath, Z, et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 2006;26(10):25992613
15.Cowan, LD, Hudson, LS. The epidemiology and natural history of infantile spasms. J Child Neurol 1991;6(4):355364
16.Riikonen, R, Donner, M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland. Dev Med Child Neurol 1979;21(3):333343
17.Sidenvall, R, Eeg-Olofsson, O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36(6):572574
18.Gaily, E, Lommi, M, Lapatto, R, Lehesjoki, AE. Incidence and outcome of epilepsy syndromes with onset in the first year of life: a retrospective population-based study. Epilepsia 2016;57(10):15941601
19.Cone, TE, Jr. On a peculiar form of infantile convulsions (hypsarrhythmia) as described in his own infant son by Dr W.J. West in 1841. Pediatrics 1970;46(4):603
20.Gibbs, EL, Fleming, MM, Gibbs, FA. Diagnosis and prognosis of hypsarhythmia and infantile spasms. Pediatrics 1954;13(1):6673
21.Cerullo, A, Marini, C, Carcangiu, R, Baruzzi, A, Tinuper, P. Clinical and video-polygraphic features of epileptic spasms in adults with cortical migration disorder. Epileptic Disord 1999;1(1):2733
22.Watanabe, K, Negoro, T, Okumura, A. Symptomatology of infantile spasms. Brain Dev 2001;23(7):453466
23.Lortie, A, Plouin, P, Chiron, C, Delalande, O, Dulac, O. Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy Res 2002;51(1–2):133145
24.Donat, JF, Wright, FS. Simultaneous infantile spasms and partial seizures. J Child Neurol 1991;6(3):246250
25.Donat, JF, Wright, FS. Unusual variants of infantile spasms. J Child Neurol 1991;6(4):313318
26.Hrachovy, RA, Frost, JD, Jr, Kellaway, P. Hypsarrhythmia: variations on the theme. Epilepsia 1984;25(3):317325
27.Caraballo, RH, Ruggieri, V, Gonzalez, G, et al. Infantile spams without hypsarrhythmia: a study of 16 cases. Seizure 2011;20(3):197202
28.Hussain, SA, Kwong, G, Millichap, JJ, et al. Hypsarrhythmia assessment exhibits poor interrater reliability: a threat to clinical trial validity. Epilepsia 2015;56(1):7781
29.Fusco, L, Vigevano, F. Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 1993;34(4):671678
30.Wilmshurst, JM, Gaillard, WD, Vinayan, KP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia 2015;56(8):11851197
31.Wirrell, EC, Shellhaas, RA, Joshi, C, et al. How should children with West syndrome be efficiently and accurately investigated?: results from the National Infantile Spasms Consortium. Epilepsia 2015;56(4):617625
32.Mercimek-Mahmutoglu, S, Patel, J, Cordeiro, D, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia 2015;56(5):707716
33.Helbig, KL, Farwell Hagman, KD, Shinde, DN, et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genet Med 2016;18(9):898905
34.Mackay, MT, Weiss, SK, Adams-Webber, T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62(10):16681681
35.Knupp, KG, Coryell, J, Nickels, KC, et al. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol 2016;79(3):475484
36.Riikonen, RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol 2010;14(1):1318
37.Camfield, P, Camfield, C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia 2007;48(6):11281132
38.Riikonen, R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996;37(4):367372
39.Riikonen, R. Long-term outcome of patients with West syndrome. Brain Dev 2001;23(7):683687
40.Coppola, G, Plouin, P, Chiron, C, Robain, O, Dulac, O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia 1995;36(10):10171024
41.McTague, A, Appleton, R, Avula, S, et al. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain 2013;136(Pt 5):15781591
42.Coppola, G. Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology. Epilepsia 2009;50(Suppl 5):4951
43.Freilich, ER, Jones, JM, Gaillard, WD, et al. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. Arch Neurol 2011;68(5):665671
44.Poduri, A, Chopra, SS, Neilan, EG, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 2012;53(8):e146e150
45.Milh, M, Falace, A, Villeneuve, N, et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat 2013;34(6):869872
46.Poduri, A, Heinzen, EL, Chitsazzadeh, V, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 2013;74(6):873882
47.Dhamija, R, Wirrell, E, Falcao, G, Kirmani, S, Wong-Kisiel, LC. Novel de novo SCN2A mutation in a child with migrating focal seizures of infancy. Pediatr Neurol 2013;49(6):486488
48.Barcia, G, Fleming, MR, Deligniere, A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012;44(11):12551259
49.Ohba, C, Kato, M, Takahashi, S, et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia 2014;55(7):9941000
50.Coppola, G, Veggiotti, P, Del Giudice, EM, et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy. Brain Dev 2006;28(2):7679
51.Lim, BC, Hwang, H, Kim, H, et al. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: migrating partial seizures of infancy or atypical Dravet syndrome? Epilepsy Res 2015;109:3439
52.Iyer, RS, Thanikasalam, , Krishnan, M. Migrating partial seizures in infancy and 47XYY syndrome: cause or coincidence? Epilepsy Behav Case Rep 2014;2:4345
53.De Filippo, MR, Rizzo, F, Marchese, G, et al. Lack of pathogenic mutations in six patients with MMPSI. Epilepsy Res 2014;108(2):340344
54.Merdariu, D, Delanoe, C, Mahfoufi, N, Bellavoine, V, Auvin, S. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. Brain Dev 2013;35(2):177180
55.Djuric, M, Kravljanac, R, Kovacevic, G, Martic, J. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy. Epileptic Disord 2011;13(1):2226
56.Vendrame, M, Poduri, A, Loddenkemper, T, et al. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. Epileptic Disord 2011;13(1):1821
57.Caraballo, R, Noli, D, Cachia, P. Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet. Epileptic Disord 2015;17(2):194197
58.Caraballo, RH, Valenzuela, GR, Armeno, M, et al. The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus. Epileptic Disord 2015;17(4):491495
59.Cilio, MR, Bianchi, R, Balestri, M, et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009;86(1):6671
60.Irahara, K, Saito, Y, Sugai, K, et al. Effects of acetazolamide on epileptic apnea in migrating partial seizures in infancy. Epilepsy Res 2011;96(1–2):185189
61.Unver, O, Incecik, F, Dundar, H, et al. Potassium bromide for treatment of malignant migrating partial seizures in infancy. Pediatr Neurol 2013;49(5):355357
62.Saade, D, Joshi, C. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. Pediatr Neurol 2015;52(5):544547
63.Bearden, D, Strong, A, Ehnot, J, et al. Targeted treatment of migrating partial seizures of infancy with quinidine. Ann Neurol 2014;76(3):457461
64.Mikati, MA, Jiang, YH, Carboni, M, et al. Quinidine in the treatment of KCNT1-positive epilepsies. Ann Neurol 2015;78(6):995999
65.Bearden, D, DiGiovine, M, Dlugos, D, Goldberg, E. Reply. Ann Neurol 2016;79(3):503504
66.Engel, J, Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796803
67.Fujiwara, T, Sugawara, T, Mazaki-Miyazaki, E, et al. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic–clonic seizures. Brain 2003;126(Pt 3):531546
68.Berkovic, SF, Harkin, L, McMahon, JM, et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006;5(6):488492
69.Jansen, FE, Sadleir, LG, Harkin, LA, et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006;67(12):22242226
70.Wolff, M, Casse-Perrot, C, Dravet, C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006;47(Suppl 2):4548
71.Scheffer, IE, Turner, SJ, Dibbens, LM, et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008;131(Pt 4):918927
72.Devinsky, O, Nabbout, R, Miller, I, et al. Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial. Epilepsia 2019;60(2):294302
73.Bialer, M, Johannessen, SI, Koepp, MJ, et al. Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development. Epilepsia 2018;59(10):18111841
74.Genton, P, Velizarova, R, Dravet, C. Dravet syndrome: the long-term outcome. Epilepsia 2011;52(Suppl 2):4449
75.Akiyama, M, Kobayashi, K, Yoshinaga, H, Ohtsuka, Y. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010;51(6):10431052
76.Camfield, PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia 2011;52(Suppl 5):39
77.Proposal for revised classification of epilepsies and epileptic syndromes: Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30(4):389399
78.Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512521
79.Cherian, A, Jabeen, SA, Kandadai, RM, et al. Epilepsy with myoclonic absences in siblings. Brain Dev 2014;36(10):892898
80.Bureau, M, Tassinari, CA. Epilepsy with myoclonic absences. Brain Dev 2005;27(3):178184
81.Kalviainen, R. Progressive myoclonus epilepsies. Semin Neurol 2015;35(3):293299
82.Vaca, GF, Lenz, T, Knight, EM, Tuxhorn, I. Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. Epileptic Disord 2012;14(2):155158
83.Gastaut, H, Tassinari, CA. Triggering mechanisms in epilepsy: the electroclinical point of view. Epilepsia 1966;7(2):85138
84.Arzimanoglou, A, Resnick, T. All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome … but many do. Epileptic Disord 2011;13(Suppl 1):S3S13
85.Arzimanoglou, A, Resnick, T. Diagnosing and treating epileptic drop attacks, atypical absences and episodes of nonconvulsive status epilepticus. Epileptic Disord 2011;13(Suppl 1):S1-S2
86.Wyllie, E, Lachhwani, DK, Gupta, A, et al. Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology 2007;69(4):389397
87.Gupta, A, Chirla, A, Wyllie, E, et al. Pediatric epilepsy surgery in focal lesions and generalized electroencephalogram abnormalities. Pediatr Neurol 2007;37(1):815
88.Carvill, GL, Heavin, SB, Yendle, SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45(7):825830
89.Allen, AS, Berkovic, SF, Cossette, P, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501(7466):217221
90.Dravet, C, Natale, O, Magaudda, A, et al. [Status epilepticus in the Lennox-Gastaut syndrome]. Rev Electroencephalogr Neurophysiol Clin 1986;15(4):361368
91.Sinclair, DB. Prednisone therapy in pediatric epilepsy. Pediatr Neurol 2003;28(3):194198
92.Yamatogi, Y, Ohtsuka, Y, Ishida, T, et al. Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev 1979;1(4):267276
93.Bello-Espinosa, LE, Rajapakse, T, Rho, JM, Buchhalter, J. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Pediatr Neurol 2015;52(5):509516
94.Billiau, AD, Witters, P, Ceulemans, B, et al. Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia 2007;48(9):17391749
95.Kossoff, EH, Krauss, GL, McGrogan, JR, Freeman, JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003;61(12):17891791
96.Kossoff, EH, McGrogan, JR, Bluml, RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47(2):421424
97.Sirven, J, Whedon, B, Caplan, D, et al. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 1999;40(12):17211726
98.Lancman, G, Virk, M, Shao, H, et al. Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis. Seizure 2013;22(1):38
99.Iwasaki, M, Uematsu, M, Nakayama, T, et al. Parental satisfaction and seizure outcome after corpus callosotomy in patients with infantile or early childhood onset epilepsy. Seizure 2013;22(4):303305
100.Maehara, T, Shimizu, H. Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia 2001;42(1):6771
101.Park, MS, Nakagawa, E, Schoenberg, MR, Benbadis, SR, Vale, FL. Outcome of corpus callosotomy in adults. Epilepsy Behav 2013;28(2):181184
102.Roger, J, Remy, C, Bureau, M, et al. [Lennox-Gastaut syndrome in the adult]. Rev Neurol (Paris) 1987;143(5):401405
103.Boyer, JP, Deschatrette, A, Delwarde, M. [Convulsive autism?: apropos of 9 cases of primary autism associated with the Lennox-Gastaut syndrome]. Pediatrie 1981;36(5):353368
104.Camfield, C, Camfield, P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol 2008;50(11):859863
105.Doose, H, Gerken, H, Leonhardt, R, Volzke, E, Volz, C. Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigation. Neuropadiatrie 1970;2(1):5978
106.Guerrini, R, Aicardi, J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J Clin Neurophysiol 2003;20(6):449461
107.Harkin, LA, McMahon, JM, Iona, X, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007;130(Pt 3):843852
108.Kilaru, S, Bergqvist, AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia 2007;48(9):17031707
109.Oguni, H, Tanaka, T, Hayashi, K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33(3):122132
110.Camfield, P, Camfield, C. Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia 2002;43(Suppl 3):2732
111.Caraballo, RH, Cejas, N, Chamorro, N, et al. Landau-Kleffner syndrome: a study of 29 patients. Seizure 2014;23(2):98104
112.Sánchez Fernández, I, Loddenkemper, T, Peters, JM, Kothare, SV. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol 2012;47(6):390410
113.Fernandez, IS, Chapman, KE, Peters, JM, et al. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia 2013;54(4):741750
114.Van Hirtum-Das, M, Licht, EA, Koh, S, et al. Children with ESES: variability in the syndrome. Epilepsy Res 2006;70(Suppl 1):S248S258
115.Loddenkemper, T, Cosmo, G, Kotagal, P, et al. Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery 2009;64(2):328337
116.Sánchez Fernández, I, Chapman, KE, Peters, JM, et al. Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management. Epilepsy Res Treat 2013;2013:583531
117.Turner, SJ, Morgan, AT, Perez, ER, Scheffer, IE. New genes for focal epilepsies with speech and language disorders. Curr Neurol Neurosci Rep 2015;15(6):35
118.Lal, D, Steinbrucker, S, Schubert, J, et al. Investigation of GRIN2A in common epilepsy phenotypes. Epilepsy Res 2015;115:9599
119.Vigevano, F, Arzimanoglou, A, Plouin, P, Specchio, N. Therapeutic approach to epileptic encephalopathies. Epilepsia 2013;54(Suppl 8):4550
120.Veggiotti, P, Pera, MC, Teutonico, F, et al. Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): an update. Epileptic Disord 2012;14(1):111
121.Inutsuka, M, Kobayashi, K, Oka, M, Hattori, J, Ohtsuka, Y. Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 2006;28(5):281286
122.Mikati, MA, Shamseddine, AN. Management of Landau-Kleffner syndrome. Paediatr Drugs 2005;7(6):377389
123.Okuyaz, C, Aydin, K, Gucuyener, K, Serdaroglu, A. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol 2005;32(1):6467
124.Wilson, RB, Eliyan, Y, Sankar, R, Hussain, SA. Amantadine: a new treatment for refractory electrical status epilepticus in sleep. Epilepsy Behav 2018;84:7478
125.Gross-Selbeck, G. Treatment of “benign” partial epilepsies of childhood, including atypical forms. Neuropediatrics 1995;26(1):4550
126.Raybarman, C. Landau-Kleffner syndrome: a case report. Neurol India 2002;50(2):212213
127.Fainberg, N, Harper, A, Tchapyjnikov, D, Mikati, MA. Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation. Epileptic Disord 2016;18(1):97100
128.Mikati, MA, Saab, R. Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome. Epilepsia 2000;41(7):880886
129.Irwin, K, Birch, V, Lees, J, et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol 2001;43(4):248252
130.Pierson, TM, Yuan, H, Marsh, ED, et al. GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. Ann Clin Transl Neurol 2014;1(3):190198
131.Ben-Ari, Y, Holmes, GL. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 2006;5(12):10551063
132.Holmes, GL, Lenck-Santini, PP. Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy Behav 2006;8(3):504515
133.Holmes, GL. Clinical evidence that epilepsy is a progressive disorder with special emphasis on epilepsy syndromes that do progress. Adv Neurol 2006;97:323331
134.Shatskikh, TN, Raghavendra, M, Zhao, Q, Cui, Z, Holmes, GL. Electrical induction of spikes in the hippocampus impairs recognition capacity and spatial memory in rats. Epilepsy Behav 2006;9(4):549556
135.Hernan, AE, Alexander, A, Lenck-Santini, PP, Scott, RC, Holmes, GL. Attention deficit associated with early life interictal spikes in a rat model is improved with ACTH. PLoS One 2014;9(2):e89812
136.Nordli, DR, Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):4856
137.Janz, D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985;72(5):449459
138.Wirrell, EC, Camfield, CS, Camfield, PR, Gordon, KE, Dooley, JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47(4):912918
139.Panayiotopoulos, CP. Idiopathic generalized epilepsies: a review and modern approach. Epilepsia 2005;46(Suppl 9):16
140.Camfield, CS, Camfield, PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009;73(13):10411045
141.Glauser, T, Ben-Menachem, E, Bourgeois, B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54(3):551563
142.Camfield, C, Camfield, P. Management guidelines for children with idiopathic generalized epilepsy. Epilepsia 2005;46(Suppl 9):112116
143.Baykan, B, Altindag, EA, Bebek, N, et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008;70(22 Pt 2): 21232129
144.Striano, S, Capovilla, G, Sofia, V, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia 2009;50(Suppl 5):1519
145.Engel, J, Jr. Report of the ILAE classification core group. Epilepsia 2006;47(9):15581568
146.Jeavons, PM. Nosological problems of myoclonic epilepsies in childhood and adolescence. Dev Med Child Neurol 1977;19(1):38
147.Yang, ZX, Cai, X, Liu, XY, Qin, J. Relationship among eye condition sensitivities, photosensitivity and epileptic syndromes. Chin Med J (Engl) 2008;121(17):16331637
148.Striano, S, Striano, P, Nocerino, C, et al. Eyelid myoclonia with absences: an overlooked epileptic syndrome? Neurophysiol Clin 2002;32(5):287296
149.Adachi, N, Kanemoto, K, Muramatsu, R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia 2005;46(9):15021509
150.Viravan, S, Go, C, Ochi, A, et al. Jeavons syndrome existing as occipital cortex initiating generalized epilepsy. Epilepsia 2011;52(7):12731279
151.Striano, P, Sofia, V, Capovilla, G, et al. A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). Epilepsia 2008;49(3):425430
152.Jung, DE, Yu, R, Yoon, JR, et al. Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Neurology 2015;84(23):23122319
153.Molokwu, OA, Ezeala-Adikaibe, BA, Onwuekwe, IO. Levetiracetam-induced rage and suicidality: two case reports and review of literature. Epilepsy Behav Case Rep 2015;4:7981
154.Menon, R, Baheti, NN, Cherian, A, Iyer, RS. Oxcarbazepine induced worsening of seizures in Jeavons syndrome: lessons learnt from an interesting presentation. Neurol India 2011;59(1):7072
155.Capovilla, G, Gambardella, A, Rubboli, G, et al. Suppressive efficacy by a commercially available blue lens on PPR in 610 photosensitive epilepsy patients. Epilepsia 2006;47(3):529533
156.Cross, JH, Jayakar, P, Nordli, D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006;47(6):952959
157.Pestana Knight, EM, Schiltz, NK, Bakaki, PM, et al. In response: epilepsy surgery trends in the U.S. – differences between kids and adults. Epilepsia 2015;56(8):13211322
158.Pestana Knight, EM, Schiltz, NK, Bakaki, PM, et al. Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009. Epilepsia 2015;56(3):375381
159.Dunkley, C, Kung, J, Scott, RC, et al. Epilepsy surgery in children under 3 years. Epilepsy Res 2011;93(2–3):96106
160.Gowda, S, Salazar, F, Bingaman, WE, et al. Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatr 2010;5(6):603607
161.Wyllie, E, Comair, YG, Kotagal, P, Raja, S, Ruggieri, P. Epilepsy surgery in infants. Epilepsia 1996;37(7):625637
162.Wyllie, E, Comair, Y, Ruggieri, P, Raja, S, Prayson, R. Epilepsy surgery in the setting of periventricular leukomalacia and focal cortical dysplasia. Neurology 1996;46(3):839841
163.Wyllie, E. Surgery for catastrophic localization-related epilepsy in infants. Epilepsia 1996;37(Suppl 1):S22S25
164.Chugani, HT, Shields, WD, Shewmon, DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27(4):406413
165.Moosa, AN, Jehi, L, Marashly, A, et al. Long-term functional outcomes and their predictors after hemispherectomy in 115 children. Epilepsia 2013;54(10):17711779
166.Lee, YJ, Kang, HC, Lee, JS, et al. Resective pediatric epilepsy surgery in Lennox–Gastaut syndrome. Pediatrics 2010;125(1):e58e66
167.Lee, YJ, Lee, JS, Kang, HC, et al. Outcomes of epilepsy surgery in childhood-onset epileptic encephalopathy. Brain Dev 2014;36(6):496504
168.Moosa, AN, Gupta, A, Jehi, L, et al. Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children. Neurology 2013;80(3):253260
169.Van den Munckhof, B, van D, V, Sagi, L, et al. Treatment of electrical status epilepticus in sleep: a pooled analysis of 575 cases. Epilepsia 2015;56(11):17381746
170.Sillanpaa, M, Jalava, M, Kaleva, O, Shinnar, S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338(24):17151722
171.Looman, WS, Lindeke, LL. Children and youth with special health care needs: partnering with families for effective advocacy. J Pediatr Health Care 2008;22(2):134136
172.Camfield, PR, Gibson, PA, Douglass, LM. Strategies for transitioning to adult care for youth with Lennox–Gastaut syndrome and related disorders. Epilepsia 2011;52(Suppl 5):2127
173.Blum, RW. Introduction: improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 2002; 110(6 Pt 2):13011303
174.Kelly, AM, Kratz, B, Bielski, M, Rinehart, PM. Implementing transitions for youth with complex chronic conditions using the medical home model. Pediatrics 2002;110(6 Pt 2):13221327